Concepedia

Junichi Kamata

JK

6

Publications

671

Citations

6

H-Index

2002

Active since

Affiliations

Eisai (Japan)(Current)

Junichi Kamata is an author at Eisai (Japan) specializing in medicine, radiation oncology, and pharmacology.

Top concepts

MedicinePharmacologyRadiation OncologyTumor BiologyCancer ResearchPharmacotherapyOncologyCell BiologyDrug DiscoveryMedicinal Chemistry

Publications per year

2002–2014

6

Publications

6

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima et al. · Vascular Cell · 2014 · 478 citations · Full text

Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

Yasuhiro Funahashi, Naoko Hata Sugi, Taro Semba et al. · PubMed · 2002 · 102 citations

Pharmacotherapy, Cellular Physiology, Tumor Biology +20

Synthesis and Evaluation of Novel Pyrimido-Acridone, -Phenoxadine, and -Carbazole as Topoisomerase II Inhibitors

Junichi Kamata, Toshimi Okada, Yoshihiko Kotake et al. · Chemical and Pharmaceutical Bulletin · 2004 · 39 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +17

Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.

Katsuji Nakamura, Hiroyuki Sugumi, Atsumi Yamaguchi et al. · PubMed · 2002 · 26 citations

Antitumor Activity, Chemoprevention Strategy, Pharmacotherapy +17

A novel carbazole topoisomerase II poison, ER‐37328: potent tumoricidal activity against human solid tumors <i>in vitro</i> and <i>in vivo</i>

Katsuji Nakamura, Toshimitsu Uenaka, Takeshi Nagasu et al. · Cancer Science · 2003 · 16 citations · Full text

Rows per page

1–5 of 6